15.98
price up icon5.48%   0.83
after-market アフターアワーズ: 15.88 -0.10 -0.63%
loading
前日終値:
$15.15
開ける:
$15.265
24時間の取引高:
43,513
Relative Volume:
0.05
時価総額:
$72.28M
収益:
-
当期純損益:
$-24.77M
株価収益率:
-21.89
EPS:
-0.73
ネットキャッシュフロー:
$-17.36M
1週間 パフォーマンス:
+10.44%
1か月 パフォーマンス:
-13.90%
6か月 パフォーマンス:
+75.60%
1年 パフォーマンス:
+94.97%
1日の値動き範囲:
Value
$15.15
$16.15
1週間の範囲:
Value
$14.35
$16.15
52週間の値動き範囲:
Value
$4.5601
$76.00

Mink Therapeutics Inc Stock (INKT) Company Profile

Name
名前
Mink Therapeutics Inc
Name
セクター
Healthcare (1146)
Name
電話
212-994-8250
Name
住所
149 FIFTH AVENUE, NEW YORK
Name
職員
23
Name
Twitter
Name
次回の収益日
2024-08-13
Name
最新のSEC提出書
Name
INKT's Discussions on Twitter

INKT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
INKT
Mink Therapeutics Inc
15.98 68.52M 0 -24.77M -17.36M -0.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
389.08 99.27B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.96 62.28B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.18 59.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
707.96 43.34B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
300.14 36.72B 3.81B -644.79M -669.77M -6.24

Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-15 アップグレード H.C. Wainwright Neutral → Buy
2025-07-14 ダウングレード William Blair Outperform → Mkt Perform

Mink Therapeutics Inc (INKT) 最新ニュース

pulisher
07:10 AM

Trading Bots Trigger Alerts on MiNK Therapeutics Inc. Activity getLinesFromResByArray error: size == 0 - 더경남뉴스

07:10 AM
pulisher
11:25 AM

Is MiNK Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Gains Summary & Safe Capital Allocation Plans - Newser

11:25 AM
pulisher
06:46 AM

Using Python tools to backtest MiNK Therapeutics Inc. strategiesExit Point & Long Hold Capital Preservation Plans - Newser

06:46 AM
pulisher
12:27 PM

Statistical indicators supporting MiNK Therapeutics Inc.’s strength2025 Bull vs Bear & Comprehensive Market Scan Reports - Newser

12:27 PM
pulisher
Aug 26, 2025

Will MiNK Therapeutics Inc. stock recover after recent dropTrade Analysis Summary & Safe Capital Allocation Plans - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Analyzing net buyer seller activity in MiNK Therapeutics Inc.Trade Risk Report & Daily Profit Maximizing Tips - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Applying Elliott Wave Theory to MiNK Therapeutics Inc.July 2025 Patterns & Capital Efficiency Focused Ideas - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

MiNK Therapeutics Inc. stock volume spike explained2025 Short Interest & Fast Gaining Stock Reports - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Can MiNK Therapeutics Inc. hit a new high this monthProfit Target & Low Risk High Win Rate Stock Picks - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Major Colorectal Cancer Trial Updates: Agenus to Present BATTMAN Phase 3 Study and BOT/BAL Data - Stock Titan

Aug 26, 2025
pulisher
Aug 25, 2025

Can volume confirm reversal in MiNK Therapeutics Inc.July 2025 Recap & AI Powered Buy and Sell Recommendations - Newser

Aug 25, 2025
pulisher
Aug 23, 2025

Jobs Data: Is MiNK Therapeutics Inc. stock undervalued right nowBuy Signal & Reliable Momentum Entry Alerts - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

What is MiNK Therapeutics Inc. s P E ratio telling us2025 Institutional Moves & Safe Capital Growth Plans - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

Identifying reversal signals in MiNK Therapeutics Inc.2025 Earnings Impact & High Accuracy Investment Signals - Newser

Aug 23, 2025
pulisher
Aug 22, 2025

What institutional flow reveals about MiNK Therapeutics Inc.July 2025 Spike Watch & Weekly Top Performers Watchlists - Newser

Aug 22, 2025
pulisher
Aug 22, 2025

What moving averages say about MiNK Therapeutics Inc.2025 Market Trends & Accurate Buy Signal Alerts - Newser

Aug 22, 2025
pulisher
Aug 22, 2025

New Zacks Rank #5 Stocks: MiNK Therapeutics, Mach Natural Resources, Canadian Solar - AInvest

Aug 22, 2025
pulisher
Aug 22, 2025

New Strong Sell Stocks For August 22nd - Barchart.com

Aug 22, 2025
pulisher
Aug 22, 2025

New Strong Sell Stocks for August 22nd - The Globe and Mail

Aug 22, 2025
pulisher
Aug 21, 2025

Real time alert setup for MiNK Therapeutics Inc. performanceEarnings Recap Summary & Consistent Income Trade Ideas - Newser

Aug 21, 2025
pulisher
Aug 21, 2025

When is the best time to exit MiNK Therapeutics Inc.July 2025 Recap & AI Based Trade Execution Alerts - Newser

Aug 21, 2025
pulisher
Aug 20, 2025

Key resistance and support levels for MiNK Therapeutics Inc.2025 Price Momentum & Expert Approved Trade Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Sector ETF Data Correlates with Strength in MiNK Therapeutics Inc.July 2025 Levels & Expert Curated Trade Setups - 클래시안

Aug 20, 2025
pulisher
Aug 20, 2025

MiNK Therapeutics Cuts Q2 Cash Use 31% - AOL.com

Aug 20, 2025
pulisher
Aug 20, 2025

Using portfolio simulators with MiNK Therapeutics Inc. included2025 Dividend Review & Free High Accuracy Swing Entry Alerts - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Mink Therapeutics shares rise 2.29% intraday after Agenus announces strategic advancements in cancer treatment. - AInvest

Aug 19, 2025
pulisher
Aug 18, 2025

Resistance Break Could Fuel MiNK Therapeutics Inc. Rally2025 Dividend Review & Safe Investment Capital Preservation Plans - newsimpact.co.kr

Aug 18, 2025
pulisher
Aug 17, 2025

MiNK Therapeutics upgraded to Buy from Neutral at H.C. Wainwright - MSN

Aug 17, 2025
pulisher
Aug 16, 2025

What indicators show strength in MiNK Therapeutics Inc.Market Risk Summary & Daily Profit Focused Stock Screening - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What high frequency data says about MiNK Therapeutics Inc.July 2025 Snapshot & Free Real-Time Market Sentiment Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

HC Wainwright & Co. Upgrades MiNK Therapeutics to Buy Rating with $35 Price Target - AInvest

Aug 16, 2025
pulisher
Aug 16, 2025

MiNK Therapeutics Upgraded to Buy by H.C. Wainwright Amid Upcoming Catalysts - AInvest

Aug 16, 2025
pulisher
Aug 16, 2025

MiNK Therapeutics outlines multiple late-stage catalysts and targets Phase II gastric cancer data by end of 2025 while expanding partnerships - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q2 2025 Earnings Call Transcript - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

What momentum shifts mean for MiNK Therapeutics Inc.July 2025 Pullbacks & Capital Efficient Trade Techniques - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

MiNK Therapeutics: Strategic Momentum and Capital Raise Potential in a High-Stakes Biotech Landscape - AInvest

Aug 16, 2025
pulisher
Aug 16, 2025

How to build a dashboard for MiNK Therapeutics Inc. stockQuarterly Portfolio Summary & Free Real-Time Volume Trigger Notifications - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

MiNK Therapeutics reports Q2 EPS ($1.06) vs (73c) last year - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

MiNK Therapeutics Shares Rise After HC Wainwright Upgrade - MarketScreener

Aug 15, 2025
pulisher
Aug 15, 2025

MiNK Therapeutics shares rise 10.31% intraday after HC Wainwright upgrades to Buy. - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

MiNK Therapeutics shares rise 8.77% intraday after HC Wainwright upgrades to Buy. - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

MiNK Therapeutics: Promising Clinical Trials and Growth Prospects Lead to Buy Rating - TipRanks

Aug 15, 2025
pulisher
Aug 15, 2025

HC Wainwright Upgrades MiNK Therapeutics to Buy From Neutral - MarketScreener

Aug 15, 2025
pulisher
Aug 15, 2025

MiNK Therapeutics upgraded to Buy from Neutral by HC Wainwright & Co., PT raised to $35. - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

MiNK Therapeutics stock rating upgraded to Buy by H.C. Wainwright on financial results - Investing.com Canada

Aug 15, 2025
pulisher
Aug 15, 2025

MiNK Therapeutics Inc (INKT) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... By GuruFocus - Investing.com Canada

Aug 15, 2025
pulisher
Aug 15, 2025

MiNK Therapeutics Reports Q2 2025 Milestones and Financials - TipRanks

Aug 15, 2025
pulisher
Aug 14, 2025

MiNK Therapeutics Inc. Recovery Likely Here’s What Data Shows2025 Breakouts & Breakdowns & Free Technical Pattern Based Buy Signals - beatles.ru

Aug 14, 2025
pulisher
Aug 14, 2025

MiNK Therapeutics (INKT) and the Strategic Value of AGENT-797 in Oncology and Immune-Mediated Diseases - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

MiNK Therapeutics Q2 2025: Unraveling Key Contradictions in GvHD and ARDS Trial Strategies - AInvest

Aug 14, 2025

Mink Therapeutics Inc (INKT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
大文字化:     |  ボリューム (24 時間):